/Companies

Biotechnology Startups

22 companies tagged Biotechnology, with their investors and founders.

Solugen

Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale. The company serves customers in energy, chemicals, and related industries with cost-effective alternatives to traditional petrochemical-based manufacturing.

27 investors

Mytos

Mytos builds robotic systems that automate the manufacturing of human cells, converting input stem cells into specific cell types such as neurons and heart cells over multiple weeks. It serves developers of regenerative medicines and cell therapies, aiming to scale production that is otherwise done by hand.

11 investors

Sensible Biotechnologies

Sensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.

9 investors

SFA Therapeutics

SFA Therapeutics develops oral therapeutic candidates based on deuterated short-chain fatty acids to treat autoimmune and oncologic diseases. The company's lead program, SFA-002, is in Phase 2 development for plaque psoriasis, with additional pipeline assets targeting pancreatic cancer, liver cancer, rheumatoid arthritis, and inflammatory bowel disease.

7 investors

Uncommon Therapeutics

Uncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.

7 investors

Alixia

Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.

6 investors

Lygos

Lygos was a performance materials company that used proprietary biology and chemistry to develop sustainable, high-performance ingredients and polymers. It scaled manufacturing and commercialized products across agriculture, cleaning, personal care, and other specialty-materials markets before concluding through two strategic sales.

6 investors

Volta Labs, Inc.

Volta develops a hardware and software platform for genomics sample preparation that automates the extraction of biological information. The company serves researchers, laboratories, and healthcare organizations working in genomics, disease control, forensic science, and medicine.

6 investors

UrbanKisaan

UrbanKisaan develops machine learning models and hardware systems for accelerated plant breeding. The company creates foundation models that predict plant traits from genetic sequences and environmental data, paired with controlled-environment chambers that compress traditional multi-year breeding cycles into months by enabling rapid generations and continuous phenotype data collection.

4 investors

Atlas Discovery

AtlasDiscovery develops foundation models of patient drug response trained on pre-clinical and clinical data to improve drug trial design and success rates. The company serves pharmaceutical and biotech firms by predicting human drug responses and enabling drug rescue and development in the biotech industry.

3 investors

Nexa Labs

Nexa develops implantable microchips and herd management software for farmers to monitor cattle health and detect disease early. The platform combines subcutaneous sensors with a mobile/web interface to provide real-time health insights and breeding optimization for dairy and cattle operations.

2 investors

Paceline Bio

Play Health builds a clinical decision-support platform for healthcare providers to deliver personalized menopause and women's health care. The platform serves primary care physicians and other providers treating women navigating perimenopause and menopause.

2 investors

Scoop

Scoop converts scientific and manufacturing data into dynamic regulatory documents for drug submissions, using AI to continuously reconcile updates and maintain consistency across filings for pharmaceutical companies and regulatory teams.

2 investors

TareBio

TareBio operates a platform for developing personalized and population-level vaccines against cancer and infectious diseases by analyzing immune cells already responding to a disease and reverse-engineering the antigens that activate them. The company works in the biotechnology and vaccine development space.

2 investors

Terraferma

Ten Lives produces sustainable protein-based cat snacks and food made through fermentation instead of animal farming, reducing environmental impact and animal harm. The company targets cat owners seeking healthier, environmentally responsible pet nutrition alternatives.

2 investors

Canos

Canos offers a liquid biopsy service for pets that sequences cell-free DNA from a single blood draw to detect cancer signals through fragmentation, copy number variation, and methylation analysis, enabling annual baseline tracking and monitoring of diagnosed animals. Working with mobile vets and clinics in San Francisco and New York, it serves dog owners, with plans to extend to cats.

1 investor

Eugit Therapeutics

Tissue Targeting Therapies develops therapeutics targeting specific tissues using computational genomics and immunology. The company serves patients through drug development in the biotech/medtech space.

1 investor

Evolvere BioSciences

Evolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.

1 investor

Lux Foods

Lux Foods develops ultra-compact plant varieties that yield mostly fruit and grows them on sugar with minimal light, pairing engineered biology with hardware suited to robotic farming. The company produces year-round, pesticide-free fruit—beginning with cherry tomatoes—for local markets in the controlled-environment agriculture sector.

1 investor

Nitroduck

Nitroduck develops gene-editing technology for fruit and vegetable crops, aimed at reducing reliance on pesticides and helping plants tolerate conditions like heat and reduced pollination. The company's tools are intended for crop breeders seeking to create new varieties with traits such as seedlessness or non-browning flesh.

1 investor

Primordiant

SuperRadiant develops general-purpose robotic systems that combine scientific reasoning with physical experimentation, observing, forming hypotheses, and running experiments to pursue scientific discovery. The systems are aimed at automating the experimental research process.

1 investor

TAXA Biotechnologies

Taxa Biotechnologies operates a platform for metabolic and genetic engineering of plants, offering protein engineering, DNA assembly, transient experiments, and stable transformation as a service without lab access. Its products are designed to avoid regulatory approval so they can be sold to consumers in the United States immediately after development.

1 investor

Other sectors & tags